The nor-1 gene is involved in aflatoxin biosynthesis in Aspergillus parasiticus and was predicted to encode a norsolorinic acid ketoreductase. Recombinant Nor-1 expressed in Escherichia coli converted the 1 keto group of norsolorinic acid to the 1 hydroxyl group of averantin in crude E. coli cell extracts in the presence of NADPH. The results confirm that Nor-1 functions as a ketoreductase in vitro.
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Preparation of recombinant Nor-1 proteins MBP-Nor-1c and Nor-1c. pMN1 was transformed into E. coli DH5␣ and induced to express fusion proteins by standard methods (1) . Recombinant fusion proteins (known as MBP-Nor-1c proteins) produced by cultures of selected transformants were purified by standard procedures described in the Protein Fusion and Purification system (New England Biolabs, Inc.). Two MBP-Nor-1c proteins with apparent 74-(major) and 78-kDa (minor) masses were detected in E. coli cell extracts by sodium dodecyl sulfate polyacrylamide gel electrophoresis (Fig. 1) . These proteins were not observed in extracts from noninduced cells, in control cells containing pMAL-c2, or in cells without vectors, suggesting that they are recombinant Nor-1 proteins expressed from nor-1 cDNA in pMN1. According to cDNA and genomic sequence data, MBP-Nor-1c proteins lacked the first two amino acid residues (M and T) of the Nor-1 coding sequence (12) which were replaced by eight amino acids (I, S, E, L, I, R, H, and E) from pMAL-c2 during vector construction.
The 74-and 78-kDa MBP-Nor-1c proteins were purified by affinity chromatography with amylose resin. These proteins could not be purified from E. coli control cultures (i.e., in cells with no vector, cells with pMAL-c2, or noninduced cells with pMN1), providing additional evidence that these MBP-Nor-1c fusion proteins are expressed from the cloned nor-1 cDNA in pMN1. The resulting proteins in a column buffer (10 mM phosphate, 0.5 M NaCl, 1 mM azide, 10 mM 2-mercaptoethanol, and 1 mM EGTA [pH 7.2]) were concentrated to 1 mg/ml (Centriprep concentrator; Amicon, Inc., Beverly, Mass.), dialyzed against Factor Xa buffer (20 mM Tris-HCl, 100 mM NaCl, 2 mM CaCl 2 , 1 mM azide [pH 8.0]) and cut with Factor Xa. This protease, supplied with the pMAL-c2 expression kit, removes MBP to generate MBP (42 kDa) and two recombinant Nor-1 proteins (Nor-1c) with apparent molecular masses of 32 (major) and 36 (minor) kDa (Fig. 2) . Since Factor Xa cuts upstream from the amino acid sequence ISELIRHE, these eight residues were predicted to be present in purified Nor-1c.
Preparation of reaction substrate NA. ⌬Nor-1, a nor-1-disrupted strain of A. parasiticus (13) , was used to prepare NA as a potential substrate for Nor-1 activity. Conidia (ϳ10 8 ) of ⌬Nor-1 were cultured in 2 liters of yeast extract-sucrose liquid medium for 2 days at 29°C with constant shaking (150 rpm) in the dark; they were then incubated without shaking at 30°C in the dark for an additional 13 days. Red-colored mycelia (250 g [wet weight]) were collected by filtration and extracted three times with 300 ml of acetone. The acetone extracts were combined and dried with a Rotovapor R110 (Brinkmann Instruments, Inc., Westbury, N.Y.) at 65°C. The resulting solid was resuspended in 100 ml of chloroform which was concentrated (Rotovapor R110; 72°C) to 6 ml and extracted again with 100 ml of acetone. Purple-red NA was purified by preparative thin-layer chromatography (TLC) with PKF silica gel 60 Å chromatography plates (20 by 20 cm; Whatman, Inc., Clifton, N.J.) with chloroform-acetone (9:1) as the developing system. NA (as a brown-colored spot) was scraped from the TLC plate with a razor blade, and the NA was extracted with a small volume of chloroform.
This compound was confirmed to be NA by TLC (with a benzene-ethyl acetate [7:3] developing system) and by UV/ visible light (VIS) spectroscopy, mass spectroscopy, and nuclear magnetic resonance (NMR) spectroscopy. UV/VIS spectroscopy was conducted with a UV/VIS spectrophotometer (CARY 3E; Varian-Australia Parity, Ltd.). Mass spectrometry was carried out on a double-focusing mass spectrometer (JEOL AX-505H; Varian-Australia Parity, Ltd.) under the following conditions: electron energy, 70 eV, and scan range, m/z 45 to 600. 1 H proton NMR spectroscopy was performed with an NMR spectrometer (VX12-500; Varian-Australia Parity, Ltd.) under the following conditions: proton probe, 80 mHz; range, 0 to 12 ppm; solvent, deuterated dimethyl sulfoxide. The UV/VIS spectrum (200 to 600 nm), the mass spectrum, and the NMR spectrum of the purified compound were consistent with published data for NA (7) .
Enzyme activity of recombinant Nor-1. The enzyme assay was conducted according to a published method (13) with modifications. The reaction mixture included protein (70 to 105 g), NA (90 mol), NADPH (0.23 mol), KH 2 PO 4 (90 mM [pH 7.5]), and 10% (vol/vol) glycerol in a total volume of 100 l. Reactions were conducted at 37°C in the dark for 30 to 90 min, and stopped by addition of 900 l of ethyl acetate. The ethyl acetate was air dried, the residue was extracted by adding 400 l of chloroform, and the reaction products in chloroform extract were resolved by TLC (HPK silica gel 60 Å [10 by 10 cm]; Whatman, Inc.) with benzene-ethyl acetate (7:3) as the developing system (Fig. 2) .
In the presence of NADPH, an E. coli crude cell extract containing MBP-Nor-1c (Fig. 2, lane 6) , affinity-purified Nor-1c plus a control cell extract (10,000 ϫ g supernatant of E. coli DH5␣ without pMN1) (lane 8), and affinity-purified MBPNor-1c plus control cell extract (results not shown) converted NA to a compound which comigrated with AVN in TLC analysis. The control cell extract (lane 4) and a crude cell extract of E. coli containing pMAL-c2 (lane 5) were unable to convert NA to AVN in the presence of NADPH. NADPH alone failed to convert NA (lane 3). These data suggested that recombinant Nor-1 used NA as a substrate and converted it to AVN. The data also suggested that E. coli provided a helper activity required for Nor-1c activity in vitro. Cell fractionation demonstrated that the helper activity was found in the soluble fraction (105,000 ϫ g supernatant) and not in the membrane fraction (105,000 ϫ g pellet) (data not shown).
Identification of the reaction end product. Standard AVN was prepared and purified by the method of Bennett et al. (2) with modifications. A. parasiticus ATCC 56774 accumulates AVN and was used to produce this AF pathway intermediate (2) . The culture conditions were the same as described above for NA purification. Orange-colored mycelia (210 g [wet weight]) were collected by filtration and extracted with acetone until colorless. Water was added (30%, vol/vol) to the combined acetone extracts, the solution was washed with hexane (1:1 ratio), and the orange pigments were extracted from the acetone phase with chloroform (1:1 ratio). The chloroform extract was concentrated to 5 ml at room temperature and the AVN was purified by preparative TLC (HPK silica gel 60 Å [20 by 20 cm]; Whatman, Inc.) with chloroform-acetone (9:1) as the developing system. AVN (as a yellow-brown-colored spot) was scraped from the TLC with a razor blade and extracted with a small volume of chloroform.
To identify the end product of the reaction catalyzed by Nor-1c, the reaction was scaled up 10-fold. The end product was tentatively identified as AVN by TLC (with benzene-ethyl acetate [7:3] as the developing system) because it had the same R f value and color as the pure AVN standard. The end product was scraped from the TLC plate and analyzed by UV/VIS spectroscopy, mass spectroscopy, and NMR spectroscopy to confirm its identity. The UV/VIS spectrum (200 to 600 nm) and the NMR spectrum were consistent with data for AVN published by Bennett et al. (2) . The NMR spectrum was less consistent with AVN data reported by Birkinshaw et al. (4) , although differences may be attributable to differences in solvent system and instrumentation. The mass spectrum was also consistent with published data for AVN (2) except for the molecular ion at m/z 371 which was reported at m/z 372, the predicted mass/charge ratio for AVN. This discrepancy is not unusual. Often, (M -1) ϩ ions are observed in mass spectroscopy due to a loss of hydrogen atom(s) from the molecular ion M ϩ ; indeed, the (M -1) ϩ ion may be more abundant than the expected molecular ion M ϩ (11). Of critical importance, the mass spectrum of the end product and standard AVN were identical. The preponderance of physical data is consistent with the ability of Nor-1c to convert NA (370 Da) to AVN (372 Da) by keto reduction.
Discussion. Recombinant Nor-1c catalyzed the conversion of the 1Ј keto group of NA to the 1Ј hydroxyl group of AVN in the presence of NADPH, confirming that the protein is an NADPH-dependent NA ketoreductase (alcohol dehydrogenase) in vitro. In previous studies, disruption of nor-1 resulted in the accumulation of NA; complementation of a nor-1 mutant restored AF synthesis (13) . These data support the hypothesis that native Nor-1 catalyzes the conversion of NA to AVN in A. parasiticus. Although it is clear that another enzyme can bypass the Nor-1-catalyzed step, the gene encoding this activity has not been identified. Cloning of this gene or purification of the enzyme activity should allow us to define more clearly the potential pathways for the conversion of NA to aflatoxin B 1 in the fungus.
We observed that a soluble compound in E. coli DH5␣ was required for Nor-1c activity. The simplest explanation is that modification of the amino terminus of Nor-1c resulted in dependence on the soluble factor. Surprisingly, purification of a 31-kDa NA reductase has not been reported in previous attempts to purify a NA reductase (3, 6) . One alternative explanation is that a cofactor(s) is required for activity of the native Nor-1 protein and is lost during a step in the purification scheme in previous studies, resulting in inability to purify this enzyme. Attempts to identify this cofactor in E. coli and the proposed analogous factor in Aspergillus may provide clues about the cellular environment in which this enzyme functions. 
